Oncology
[Oncology archives]

1. Bhan S, Chuang A, Negi SS, Glazer CA, Califano JA. MAGEA4 induces growth in normal oral keratinocytes by inhibiting growth arrest and apoptosis. Oncol Rep. 2012 Jul 25. doi: 10.3892/or.2012.1934. [Epub ahead of print]
Key words: keratinocytes, oral, apoptosis
PubMed PMID: 22842486.
http://www.ncbi.nlm.nih.gov/pubmed/22842486

2. Chun YS, Bisht S, Chenna V, Pramanik D, Yoshida T, Hong SM, de Wilde RF, Zhang Z, Huso D, Zhao M, Rudek M, Stearns V, Maitra A, Sukumar S. Intraductal administration of a polymeric nanoparticle formulation of curcumin (NanoCurc) significantly attenuates incidence of mammary tumors in a rodent chemical carcinogenesis model implications for breast cancer chemoprevention in at-risk populations. Carcinogenesis. 2012 Jul 25. [Epub ahead of print]
Key words: breast cancer, curcumin, polymeric, nanoparticle
http://www.ncbi.nlm.nih.gov/pubmed/22831956

3. Denmeade SR, Isaacs JT. Engineering enzymatically activated "Molecular Grenades" for cancer. Oncotarget. 2012 Jul 22. [Epub ahead of print]
Key words: grenade, molecular, engineering
http://www.ncbi.nlm.nih.gov/pubmed/22837432

4. Manning ML, Kostova M, Williams SA, Denmeade SR. Trypsin-like proteolytic contamination of commercially available psa purified from human seminal fluid. Prostate. 2012 Aug 1;72(11):1233-8. doi: 10.1002/pros.22474. Epub 2011 Dec 28.
Key words: seminal, purified, proteolytic, contamination
http://www.ncbi.nlm.nih.gov/pubmed/22213008

5. Schweizer MT, Antonarakis ES. Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is born. Ther Adv Urol. 2012 Aug;4(4):167-78.
Key words: prostate cancer, hormonal, therapy, androgen
http://www.ncbi.nlm.nih.gov/pubmed/22852027

6. Pellakuru LG, Iwata T, Gurel B, Schultz D, Hicks J, Bethel C, Yegnasubramanian S, De Marzo AM. Global levels of H3K27me3 Track with differentiation in vivo and are deregulated by MYC in prostate cancer. Am J Pathol. 2012 Aug;181(2):560-9.
Key words: prostate cancer, deregulated, MYC, H3K27me3
http://www.ncbi.nlm.nih.gov/pubmed/22713676

7. Wenzel J, Jones RA, Klimmek R, Krumm S, Darrell LP, Song D, Stearns V, Ford JG. Cancer support and resource needs among african american older adults. Clin J Oncol Nurs. 2012 Aug 1;16(4):372-7.
Key words: support, resource, cancer, African, American
http://www.ncbi.nlm.nih.gov/pubmed/22842688

8. Williams AB, Nguyen B, Li L, Brown P, Levis M, Leahy D, Small D. Mutations of FLT3/ITD confer resistance to multiple tyrosine kinase inhibitors. Leukemia. 2012 Jul 13. doi: 10.1038/leu.2012.191. [Epub ahead of print]
Key words: tyrosine, inhibitors, kinase, FLT3
http://www.ncbi.nlm.nih.gov/pubmed/22858906

Return to top of Publications - Oncology